On fast track to defeat cancer, Peninsula startup lands $108M from A-list investors
The company, launched in spring 2019 by veterans of Pfizer's now-shuttered cancer immunotherapy research center in South San Francisco, expects to grow to about 60 employees as it takes its first drug into its first clinical trial late next year.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Health Management | Immunotherapy | Pfizer | Pharmaceuticals